Drug interactions for the following drug(s)
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> levothyroxine sodium 100 MCG Oral Tablet
The therapeutic efficacy of Levothyroxine can be increased when used in combination with Beclomethasone dipropionate.
Applies to: Plaquenil 200 MG Oral Tablet <> levothyroxine sodium 100 MCG Oral Tablet
The metabolism of Hydroxychloroquine can be decreased when combined with Levothyroxine.
Applies to: Plaquenil 200 MG Oral Tablet <> carvedilol 6.25 MG Oral Tablet
The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Carvedilol.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> budesonide 0.5 MG per 2 ML Inhalant Suspension
Folic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> Plaquenil 200 MG Oral Tablet
The metabolism of Hydroxychloroquine can be decreased when combined with Cholecalciferol.
Applies to: Flecainide Acetate 100 MG Oral Tablet <> carvedilol 6.25 MG Oral Tablet
Carvedilol may increase the arrhythmogenic activities of Flecainide.
Applies to: Plaquenil 200 MG Oral Tablet <> budesonide 0.5 MG per 2 ML Inhalant Suspension
The risk or severity of adverse effects can be increased when Budesonide is combined with Hydroxychloroquine.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> Flecainide Acetate 100 MG Oral Tablet
The metabolism of Flecainide can be decreased when combined with Cholecalciferol.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
The therapeutic efficacy of Cholecalciferol can be decreased when used in combination with Beclomethasone dipropionate.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> Plaquenil 200 MG Oral Tablet
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hydroxychloroquine.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> budesonide 0.5 MG per 2 ML Inhalant Suspension
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Budesonide.
Applies to: Flecainide Acetate 100 MG Oral Tablet <> Plaquenil 200 MG Oral Tablet
The metabolism of Flecainide can be decreased when combined with Hydroxychloroquine.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> carvedilol 6.25 MG Oral Tablet
The metabolism of Carvedilol can be decreased when combined with Cholecalciferol.
Applies to: levothyroxine sodium 100 MCG Oral Tablet <> carvedilol 6.25 MG Oral Tablet
The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Carvedilol.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> levothyroxine sodium 100 MCG Oral Tablet
Drug1 (rxcui = 966536, name = 100 ACTUAT beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler, tty = SCD). Drug2 (rxcui = 892246, name = levothyroxine sodium 0.1 MG Oral Tablet, tty = SCD). Drug1 is resolved to beclomethasone dipropionate, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Beclomethasone dipropionate and Levothyroxine.
Applies to: Plaquenil 200 MG Oral Tablet <> levothyroxine sodium 100 MCG Oral Tablet
Drug1 (rxcui = 979094, name = hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil], tty = SBD). Drug2 (rxcui = 892246, name = levothyroxine sodium 0.1 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to levothyroxine and interaction asserted in DrugBank between Hydroxychloroquine and Levothyroxine.
Applies to: Plaquenil 200 MG Oral Tablet <> carvedilol 6.25 MG Oral Tablet
Drug1 (rxcui = 979094, name = hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil], tty = SBD). Drug2 (rxcui = 200031, name = carvedilol 6.25 MG Oral Tablet, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to carvedilol and interaction asserted in DrugBank between Hydroxychloroquine and Carvedilol.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> budesonide 0.5 MG per 2 ML Inhalant Suspension
Drug1 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 351109, name = budesonide 0.25 MG/ML Inhalation Suspension, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to budesonide and interaction asserted in DrugBank between Folic acid and Budesonide. Drug1 is resolved to cholecalciferol, Drug2 is resolved to budesonide and interaction asserted in DrugBank between Cholecalciferol and Budesonide.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> Plaquenil 200 MG Oral Tablet
Drug1 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 979094, name = hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil], tty = SBD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to hydroxychloroquine and interaction asserted in DrugBank between Cholecalciferol and Hydroxychloroquine.
Applies to: Flecainide Acetate 100 MG Oral Tablet <> carvedilol 6.25 MG Oral Tablet
Drug1 (rxcui = 886666, name = flecainide acetate 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 200031, name = carvedilol 6.25 MG Oral Tablet, tty = SCD). Drug1 is resolved to flecainide, Drug2 is resolved to carvedilol and interaction asserted in DrugBank between Flecainide and Carvedilol.
Applies to: Plaquenil 200 MG Oral Tablet <> budesonide 0.5 MG per 2 ML Inhalant Suspension
Drug1 (rxcui = 979094, name = hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil], tty = SBD). Drug2 (rxcui = 351109, name = budesonide 0.25 MG/ML Inhalation Suspension, tty = SCD). Drug1 is resolved to hydroxychloroquine, Drug2 is resolved to budesonide and interaction asserted in DrugBank between Hydroxychloroquine and Budesonide.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> Flecainide Acetate 100 MG Oral Tablet
Drug1 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 886666, name = flecainide acetate 100 MG Oral Tablet, tty = SCD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to flecainide and interaction asserted in DrugBank between Cholecalciferol and Flecainide.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule
Drug1 (rxcui = 966536, name = 100 ACTUAT beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler, tty = SCD). Drug2 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to beclomethasone dipropionate, Drug2 is resolved to cholecalciferol and interaction asserted in DrugBank between Beclomethasone dipropionate and Cholecalciferol. Drug1 is resolved to beclomethasone dipropionate, Drug2 is resolved to folic acid and interaction asserted in DrugBank between Beclomethasone dipropionate and Folic acid.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> Plaquenil 200 MG Oral Tablet
Drug1 (rxcui = 966536, name = 100 ACTUAT beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler, tty = SCD). Drug2 (rxcui = 979094, name = hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil], tty = SBD). Drug1 is resolved to beclomethasone dipropionate, Drug2 is resolved to hydroxychloroquine and interaction asserted in DrugBank between Beclomethasone dipropionate and Hydroxychloroquine.
Applies to: beclomethasone dipropionate 40 MCG/ACTUAT Metered Dose Inhaler, 100 ACTUAT <> budesonide 0.5 MG per 2 ML Inhalant Suspension
Drug1 (rxcui = 966536, name = 100 ACTUAT beclomethasone dipropionate 0.04 MG/ACTUAT Metered Dose Inhaler, tty = SCD). Drug2 (rxcui = 351109, name = budesonide 0.25 MG/ML Inhalation Suspension, tty = SCD). Drug1 is resolved to beclomethasone dipropionate, Drug2 is resolved to budesonide and interaction asserted in DrugBank between Beclomethasone dipropionate and Budesonide.
Applies to: Flecainide Acetate 100 MG Oral Tablet <> Plaquenil 200 MG Oral Tablet
Drug1 (rxcui = 886666, name = flecainide acetate 100 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 979094, name = hydroxychloroquine sulfate 200 MG Oral Tablet [Plaquenil], tty = SBD). Drug1 is resolved to flecainide, Drug2 is resolved to hydroxychloroquine and interaction asserted in DrugBank between Flecainide and Hydroxychloroquine.
Applies to: vitamin D3 3775 UNT / Folic Acid 1 MG Oral Capsule <> carvedilol 6.25 MG Oral Tablet
Drug1 (rxcui = 1593744, name = cholecalciferol 3775 UNT / folic acid 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 200031, name = carvedilol 6.25 MG Oral Tablet, tty = SCD). Drug1 is resolved to cholecalciferol, Drug2 is resolved to carvedilol and interaction asserted in DrugBank between Cholecalciferol and Carvedilol.
Applies to: levothyroxine sodium 100 MCG Oral Tablet <> carvedilol 6.25 MG Oral Tablet
Drug1 (rxcui = 892246, name = levothyroxine sodium 0.1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 200031, name = carvedilol 6.25 MG Oral Tablet, tty = SCD). Drug1 is resolved to levothyroxine, Drug2 is resolved to carvedilol and interaction asserted in DrugBank between Levothyroxine and Carvedilol.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.